Egyszerű nézet

dc.contributor.author Galló, Nóra
dc.contributor.author Horváth, Klára
dc.contributor.author Czuppon, Krisztina
dc.contributor.author Tomsits, Erika
dc.contributor.author Felegyhazi, E.
dc.contributor.author Kovács, Gábor
dc.date.accessioned 2021-08-31T07:22:25Z
dc.date.available 2021-08-31T07:22:25Z
dc.date.issued 2021
dc.identifier 85107740916
dc.identifier.citation journalVolume=40;journalIssueNumber=6;journalTitle=CLINICAL NUTRITION;pagerange=3836-3841;journalAbbreviatedTitle=CLIN NUTR;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/8878
dc.identifier.uri doi:10.1016/j.clnu.2021.05.013
dc.description.abstract Background & aims: Cancer is one of the leading causes of death for children; however, appropriate nutritional status can positively affect disease progression and outcome. The aim of this study was to present our self-developed nutritional risk screening method, relate it to another validated tool and to objective bio-impedance measures. We intended to recommend a screening algorithm which can be used in our pediatric oncology facilities. Methods: We analysed data from 109 pediatric oncology patients (age 3–18) at the 2nd Department of Pediatrics, Semmelweis University between 2017 and 2018. The nutritional status was assessed by the Nutrition screening tool for childhood cancer (SCAN), Nutrition risk screening for pediatric cancer (NRS-PC) our own self-developed screening tool and Bio-impedance analysis (InBody 720 and S10). Classifier properties for low muscle mass measured by Bio-impedance analysis were compared for SCAN and NRS-PC in the overall sample and in the different phases of the disease. Results: The AUC of 0.67 [95% CI:0.58,0.75] of the SCAN was significantly lower (Z = −2.46, p = 0.014) than in the case of the NRS-PC (AUC = 0.75 [95% CI:0.67,0.82]), indicating that NRS-PC has better classifier properties to identify children with lower muscle mass. No significant difference was found in the different phases of the disease. Conclusions: Based on our results, we suggest screening high BMI patients first with NRS-PC. However, in case of low BMI bio-impedance measures provide more precise information on muscle mass and nutritional risk. Further data are needed to decide whether the NRS-PC is sensitive enough in normal BMI patients. © 2021 The Authors
dc.format.extent 3836-3841
dc.relation.ispartof urn:issn:0261-5614
dc.title Different nutritional screening tools and recommended screening algorithm for pediatric oncology patients
dc.type Journal Article
dc.date.updated 2021-07-14T09:35:53Z
dc.language.rfc3066 en
dc.rights.holder NULL
dc.identifier.mtmt 32079084
dc.contributor.department SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet